Gsk (GSK) Inventory (2009 - 2026)

Gsk (GSK) has 18 years of Inventory data on file, last reported at $8.4 billion in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 4.05% year-over-year to $8.4 billion; the trailing twelve-month figure through Jun 2026 stood at $8.4 billion (up 4.05% YoY), and the FY2025 full-year result was $7.9 billion, up 8.74% from the prior year.
• Inventory was $8.4 billion for Q2 2026 at Gsk, up from $8.3 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.4 billion in Q2 2026 to a low of $1.3 billion in Q1 2022.
• A 5-year average of $6.9 billion and a median of $7.3 billion in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory sank 84.56% in 2022 and surged 391.97% in 2023, its largest moves.
• Gsk's Inventory stood at $6.0 billion in 2022, then grew by 13.05% to $6.8 billion in 2023, then rose by 6.63% to $7.3 billion in 2024, then grew by 8.3% to $7.9 billion in 2025, then climbed by 6.96% to $8.4 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $8.4 billion in Q2 2026, $8.3 billion in Q1 2026, and $7.9 billion in Q4 2025.